XWELL (NASDAQ:XWEL) Stock Price Down 1.9% – Should You Sell?

XWELL, Inc. (NASDAQ:XWEL)’s share price dropped 1.9% during trading on Thursday . The stock traded as low as $1.0450 and last traded at $1.05. Approximately 9,468 shares traded hands during mid-day trading, a decline of 96% from the average session volume of 216,249 shares. The stock had previously closed at $1.07.

Wall Street Analysts Forecast Growth

Several analysts recently issued reports on the company. Wall Street Zen cut XWELL from a “hold” rating to a “sell” rating in a research report on Sunday, May 17th. Weiss Ratings cut shares of XWELL from a “sell (d-)” rating to a “sell (e+)” rating in a research report on Wednesday, May 13th. One analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, the company presently has an average rating of “Sell”.

XWELL Price Performance

The business has a 50-day moving average of $1.18 and a 200 day moving average of $1.02. The company has a market capitalization of $8.86 million, a PE ratio of -0.19 and a beta of 1.03.

XWELL (NASDAQ:XWEL) last released its quarterly earnings results on Wednesday, May 20th. The company reported ($1.51) earnings per share for the quarter, missing the consensus estimate of ($1.00) by ($0.51). XWELL had a negative net margin of 81.43% and a negative return on equity of 2,318.99%. The firm had revenue of $6.64 million for the quarter, compared to analysts’ expectations of $2.37 million.

About XWELL

XWELL, Inc provides health and wellness services in airport and off airport marketplaces in the United States and internationally. It operates in four segments: XpresSpa, XpresTest, Naples Wax Center, and Treat. The XpresSpa segment traveler's spa services, including massage, nail, and skin care services, as well as spa and travel products. The XpresTest segment offers diagnostic COVID-19 tests at XpresCheck Wellness Centers in airports, to airport employees and to the traveling public but has transitioned to the CDC's bio-surveillance program; and provides marketing support through HyperPointe business to various health and health-related channels.